Skip to content

XENE - Xenon Pharmaceuticals Inc. - AlphaYou

Discover Compare Pricing

Sign in Sign up

Home Smart money Buy calls Analyze

Back to stock searchX

Xenon Pharmaceuticals Inc

XENE · NASDAQ

Save to watchlist

Price is syncing

Reported smart-money activity for this stock is still below.

X

XENEXenon Pharmaceuticals Inc

Overview

No source-backed view yet. This page is available for price, fundamentals, and future receipts as coverage warms.

Key stats

Aug 20

52-wk high: $72.66
52-wk low: $35.60
Prev close: $55.66
Mkt cap: $6.11B
Beta: 0.63
P/S: 727.4x

Smart money

8 funds hold a position.

Real smart money

Funds holding this stock

8 holders

Combined position$1.6B

TS
Two Sigma
Q2 2026 13F
$99.2M
position
CI
Citadel
Ken Griffin · Q2 2026 13F

Earnings

Reported Aug 6, 2026

Earnings came in 4.3% above what analysts expected.

Documents

Quarterly report10-Q Annual report10-K

Financials

Fundamentals

Is the business strong?

This company is running thin margins.

Net margin: 0.0%
Market cap: $6.1B

Valuation

P/S727.44
P/B4.51

Quality

Operating margin0.0%
ROE

Technicals

Technicals

Price structure

No data yet

Technicals sync when verified market data is available. No sample data is shown.

Company

Symbol: XENE
Exchange: NASDAQ
Sector: HEALTHCARE
Industry: BIOTECHNOLOGY
Market cap: $6.11B
Beta: 0.63

Analysts

What do analysts expect?

Analyst target and ratings are on paid plans

See the 12-month consensus target and the buy/hold/sell rating split.

Unlock the full results

Research hubs
About
Editorial policy
Methodology
Source coverage
Corrections

Privacy
Terms
Refunds
Disclaimer

© 2026 AlphaYou. All rights reserved.Not financial advice. Do your own research. Informational data only; past performance does not predict future results.

P/B

4.5x

Profit margin

+0.0%

Op margin

+0.0%

ROE

-43.6%

$84.6M

position

MW

Marshall Wace

Q2 2026 13F

$41.6M

position

5 more holders

Lite opens all of them for $16.50/month, paid yearly.

Unlock all 5 holders

Coverage gaps for XENE

No recent insider trade
No recent Congress trade
No recent market-voice mention

Earnings per share

-$1.11+4.3%

-$1.16 expected

Next report

What the street expects next

EPS expected

-$1.16

-$1.29 to -$0.94

Revenue expected

$0.00

16 analysts

Last 30 days

8up3down

Analysts raising estimates

Estimate drift

+0.04

Change in 30 days

-43.6%

ROA-28.0%

Growth

Beta0.63